Broadly cross-reactive HIV-1-specific antibodies for prevention and treatment of HIV
Patent Number: US20130011414A1
Application Number: US13534834A
Inventor: Zhang, Mei-Yun
Priority Date: 5 Jul 2011
Priority Number: US20130011414A1
Application Date: 27 Jun 2012
Publication Date: 10 Jan 2013
IPC Current: A61K003942 | A61P003118 | C07K001610 | G01N0033569
US Class: 4241601 | 435005 | 5303894
Assignee Applicant: The University of Hong Kong
Title: BROADLY CROSS-REACTIVE HIV-1-SPECIFIC ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV
Usefulness: BROADLY CROSS-REACTIVE HIV-1-SPECIFIC ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV
Summary: For screening or generating a HIV-1 specific transforming antibody useful for prevention and/or treatment of HIV-1 infection; in the manufacture of a vaccine composition used for preventing individuals from acquiring HIV infection, and used for treating or ameliorating HIV infection (claimed).
Novelty: New HIV-1 specific transforming antibody comprising an antigen binding portion that binds to an epitope of trimeric spike of native HIV envelope glycoprotein, used in manufacture of vaccine composition for preventing/treating HIV infection
诊断/治疗
人类免疫缺陷病毒
香港
